Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe.
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.